Pharmacogenomics (PGx) Market, Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of Pharmacogenomics (PGx) in Global, including the following market information:
Global Pharmacogenomics (PGx) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Pharmacogenomics (PGx) market was valued at 7982.5 million in 2021 and is projected to reach US$ 14480 million by 2028, at a CAGR of 8.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Polymerase Chain Reaction (PCR) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pharmacogenomics (PGx) include Abbott Laboratories, Affymetrix, Inc., Assurex Health, Inc, Astrazeneca, GeneDX, Illumina, Inc., Laboratory Corporation of America Holdings, Myriad Genetics, Inc. and Pathway Genomics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pharmacogenomics (PGx) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pharmacogenomics (PGx) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Pharmacogenomics (PGx) Market Segment Percentages, by Type, 2021 (%)
Global Pharmacogenomics (PGx) Market Segment Percentages, by Application, 2021 (%)
Global Pharmacogenomics (PGx) Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Pharmacogenomics (PGx) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Pharmacogenomics (PGx) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global Pharmacogenomics (PGx) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Pharmacogenomics (PGx) market was valued at 7982.5 million in 2021 and is projected to reach US$ 14480 million by 2028, at a CAGR of 8.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Polymerase Chain Reaction (PCR) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pharmacogenomics (PGx) include Abbott Laboratories, Affymetrix, Inc., Assurex Health, Inc, Astrazeneca, GeneDX, Illumina, Inc., Laboratory Corporation of America Holdings, Myriad Genetics, Inc. and Pathway Genomics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pharmacogenomics (PGx) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pharmacogenomics (PGx) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Pharmacogenomics (PGx) Market Segment Percentages, by Type, 2021 (%)
- Polymerase Chain Reaction (PCR)
- Microarray
- Sequencing
- Other
Global Pharmacogenomics (PGx) Market Segment Percentages, by Application, 2021 (%)
- Cardiovascular Diseases (CVD)
- Central Nervous System (CNS)
- Cancer/Oncology
- Infectious Diseases
- Other
Global Pharmacogenomics (PGx) Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Pharmacogenomics (PGx) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Pharmacogenomics (PGx) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Abbott Laboratories
- Affymetrix, Inc.
- Assurex Health, Inc
- Astrazeneca
- GeneDX
- Illumina, Inc.
- Laboratory Corporation of America Holdings
- Myriad Genetics, Inc.
- Pathway Genomics
- Pfizer, Inc
- Qiagen, Inc.
- Rocheg
- Teva Pharmaceutical Industries Ltd.
- Thermo Fisher Scientific
- Transgenomic, Inc.
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Pharmacogenomics (PGx) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pharmacogenomics (PGx) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL PHARMACOGENOMICS (PGX) OVERALL MARKET SIZE
2.1 Global Pharmacogenomics (PGx) Market Size: 2021 VS 2028
2.2 Global Pharmacogenomics (PGx) Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Pharmacogenomics (PGx) Players in Global Market
3.2 Top Global Pharmacogenomics (PGx) Companies Ranked by Revenue
3.3 Global Pharmacogenomics (PGx) Revenue by Companies
3.4 Top 3 and Top 5 Pharmacogenomics (PGx) Companies in Global Market, by Revenue in 2021
3.5 Global Companies Pharmacogenomics (PGx) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pharmacogenomics (PGx) Players in Global Market
3.6.1 List of Global Tier 1 Pharmacogenomics (PGx) Companies
3.6.2 List of Global Tier 2 and Tier 3 Pharmacogenomics (PGx) Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Pharmacogenomics (PGx) Market Size Markets, 2021 & 2028
4.1.2 Polymerase Chain Reaction (PCR)
4.1.3 Microarray
4.1.4 Sequencing
4.1.5 Other
4.2 By Type - Global Pharmacogenomics (PGx) Revenue & Forecasts
4.2.1 By Type - Global Pharmacogenomics (PGx) Revenue, 2017-2022
4.2.2 By Type - Global Pharmacogenomics (PGx) Revenue, 2023-2028
4.2.3 By Type - Global Pharmacogenomics (PGx) Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Pharmacogenomics (PGx) Market Size, 2021 & 2028
5.1.2 Cardiovascular Diseases (CVD)
5.1.3 Central Nervous System (CNS)
5.1.4 Cancer/Oncology
5.1.5 Infectious Diseases
5.1.6 Other
5.2 By Application - Global Pharmacogenomics (PGx) Revenue & Forecasts
5.2.1 By Application - Global Pharmacogenomics (PGx) Revenue, 2017-2022
5.2.2 By Application - Global Pharmacogenomics (PGx) Revenue, 2023-2028
5.2.3 By Application - Global Pharmacogenomics (PGx) Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Pharmacogenomics (PGx) Market Size, 2021 & 2028
6.2 By Region - Global Pharmacogenomics (PGx) Revenue & Forecasts
6.2.1 By Region - Global Pharmacogenomics (PGx) Revenue, 2017-2022
6.2.2 By Region - Global Pharmacogenomics (PGx) Revenue, 2023-2028
6.2.3 By Region - Global Pharmacogenomics (PGx) Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Pharmacogenomics (PGx) Revenue, 2017-2028
6.3.2 US Pharmacogenomics (PGx) Market Size, 2017-2028
6.3.3 Canada Pharmacogenomics (PGx) Market Size, 2017-2028
6.3.4 Mexico Pharmacogenomics (PGx) Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Pharmacogenomics (PGx) Revenue, 2017-2028
6.4.2 Germany Pharmacogenomics (PGx) Market Size, 2017-2028
6.4.3 France Pharmacogenomics (PGx) Market Size, 2017-2028
6.4.4 U.K. Pharmacogenomics (PGx) Market Size, 2017-2028
6.4.5 Italy Pharmacogenomics (PGx) Market Size, 2017-2028
6.4.6 Russia Pharmacogenomics (PGx) Market Size, 2017-2028
6.4.7 Nordic Countries Pharmacogenomics (PGx) Market Size, 2017-2028
6.4.8 Benelux Pharmacogenomics (PGx) Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Pharmacogenomics (PGx) Revenue, 2017-2028
6.5.2 China Pharmacogenomics (PGx) Market Size, 2017-2028
6.5.3 Japan Pharmacogenomics (PGx) Market Size, 2017-2028
6.5.4 South Korea Pharmacogenomics (PGx) Market Size, 2017-2028
6.5.5 Southeast Asia Pharmacogenomics (PGx) Market Size, 2017-2028
6.5.6 India Pharmacogenomics (PGx) Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Pharmacogenomics (PGx) Revenue, 2017-2028
6.6.2 Brazil Pharmacogenomics (PGx) Market Size, 2017-2028
6.6.3 Argentina Pharmacogenomics (PGx) Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pharmacogenomics (PGx) Revenue, 2017-2028
6.7.2 Turkey Pharmacogenomics (PGx) Market Size, 2017-2028
6.7.3 Israel Pharmacogenomics (PGx) Market Size, 2017-2028
6.7.4 Saudi Arabia Pharmacogenomics (PGx) Market Size, 2017-2028
6.7.5 UAE Pharmacogenomics (PGx) Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Corporate Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Pharmacogenomics (PGx) Major Product Offerings
7.1.4 Abbott Laboratories Pharmacogenomics (PGx) Revenue in Global Market (2017-2022)
7.1.5 Abbott Laboratories Key News
7.2 Affymetrix, Inc.
7.2.1 Affymetrix, Inc. Corporate Summary
7.2.2 Affymetrix, Inc. Business Overview
7.2.3 Affymetrix, Inc. Pharmacogenomics (PGx) Major Product Offerings
7.2.4 Affymetrix, Inc. Pharmacogenomics (PGx) Revenue in Global Market (2017-2022)
7.2.5 Affymetrix, Inc. Key News
7.3 Assurex Health, Inc
7.3.1 Assurex Health, Inc Corporate Summary
7.3.2 Assurex Health, Inc Business Overview
7.3.3 Assurex Health, Inc Pharmacogenomics (PGx) Major Product Offerings
7.3.4 Assurex Health, Inc Pharmacogenomics (PGx) Revenue in Global Market (2017-2022)
7.3.5 Assurex Health, Inc Key News
7.4 Astrazeneca
7.4.1 Astrazeneca Corporate Summary
7.4.2 Astrazeneca Business Overview
7.4.3 Astrazeneca Pharmacogenomics (PGx) Major Product Offerings
7.4.4 Astrazeneca Pharmacogenomics (PGx) Revenue in Global Market (2017-2022)
7.4.5 Astrazeneca Key News
7.5 GeneDX
7.5.1 GeneDX Corporate Summary
7.5.2 GeneDX Business Overview
7.5.3 GeneDX Pharmacogenomics (PGx) Major Product Offerings
7.5.4 GeneDX Pharmacogenomics (PGx) Revenue in Global Market (2017-2022)
7.5.5 GeneDX Key News
7.6 Illumina, Inc.
7.6.1 Illumina, Inc. Corporate Summary
7.6.2 Illumina, Inc. Business Overview
7.6.3 Illumina, Inc. Pharmacogenomics (PGx) Major Product Offerings
7.6.4 Illumina, Inc. Pharmacogenomics (PGx) Revenue in Global Market (2017-2022)
7.6.5 Illumina, Inc. Key News
7.7 Laboratory Corporation of America Holdings
7.7.1 Laboratory Corporation of America Holdings Corporate Summary
7.7.2 Laboratory Corporation of America Holdings Business Overview
7.7.3 Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Major Product Offerings
7.7.4 Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Revenue in Global Market (2017-2022)
7.7.5 Laboratory Corporation of America Holdings Key News
7.8 Myriad Genetics, Inc.
7.8.1 Myriad Genetics, Inc. Corporate Summary
7.8.2 Myriad Genetics, Inc. Business Overview
7.8.3 Myriad Genetics, Inc. Pharmacogenomics (PGx) Major Product Offerings
7.8.4 Myriad Genetics, Inc. Pharmacogenomics (PGx) Revenue in Global Market (2017-2022)
7.8.5 Myriad Genetics, Inc. Key News
7.9 Pathway Genomics
7.9.1 Pathway Genomics Corporate Summary
7.9.2 Pathway Genomics Business Overview
7.9.3 Pathway Genomics Pharmacogenomics (PGx) Major Product Offerings
7.9.4 Pathway Genomics Pharmacogenomics (PGx) Revenue in Global Market (2017-2022)
7.9.5 Pathway Genomics Key News
7.10 Pfizer, Inc
7.10.1 Pfizer, Inc Corporate Summary
7.10.2 Pfizer, Inc Business Overview
7.10.3 Pfizer, Inc Pharmacogenomics (PGx) Major Product Offerings
7.10.4 Pfizer, Inc Pharmacogenomics (PGx) Revenue in Global Market (2017-2022)
7.10.5 Pfizer, Inc Key News
7.11 Qiagen, Inc.
7.11.1 Qiagen, Inc. Corporate Summary
7.11.2 Qiagen, Inc. Business Overview
7.11.3 Qiagen, Inc. Pharmacogenomics (PGx) Major Product Offerings
7.11.4 Qiagen, Inc. Pharmacogenomics (PGx) Revenue in Global Market (2017-2022)
7.11.5 Qiagen, Inc. Key News
7.12 Rocheg
7.12.1 Rocheg Corporate Summary
7.12.2 Rocheg Business Overview
7.12.3 Rocheg Pharmacogenomics (PGx) Major Product Offerings
7.12.4 Rocheg Pharmacogenomics (PGx) Revenue in Global Market (2017-2022)
7.12.5 Rocheg Key News
7.13 Teva Pharmaceutical Industries Ltd.
7.13.1 Teva Pharmaceutical Industries Ltd. Corporate Summary
7.13.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.13.3 Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Major Product Offerings
7.13.4 Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Revenue in Global Market (2017-2022)
7.13.5 Teva Pharmaceutical Industries Ltd. Key News
7.14 Thermo Fisher Scientific
7.14.1 Thermo Fisher Scientific Corporate Summary
7.14.2 Thermo Fisher Scientific Business Overview
7.14.3 Thermo Fisher Scientific Pharmacogenomics (PGx) Major Product Offerings
7.14.4 Thermo Fisher Scientific Pharmacogenomics (PGx) Revenue in Global Market (2017-2022)
7.14.5 Thermo Fisher Scientific Key News
7.15 Transgenomic, Inc.
7.15.1 Transgenomic, Inc. Corporate Summary
7.15.2 Transgenomic, Inc. Business Overview
7.15.3 Transgenomic, Inc. Pharmacogenomics (PGx) Major Product Offerings
7.15.4 Transgenomic, Inc. Pharmacogenomics (PGx) Revenue in Global Market (2017-2022)
7.15.5 Transgenomic, Inc. Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 Pharmacogenomics (PGx) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pharmacogenomics (PGx) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL PHARMACOGENOMICS (PGX) OVERALL MARKET SIZE
2.1 Global Pharmacogenomics (PGx) Market Size: 2021 VS 2028
2.2 Global Pharmacogenomics (PGx) Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Pharmacogenomics (PGx) Players in Global Market
3.2 Top Global Pharmacogenomics (PGx) Companies Ranked by Revenue
3.3 Global Pharmacogenomics (PGx) Revenue by Companies
3.4 Top 3 and Top 5 Pharmacogenomics (PGx) Companies in Global Market, by Revenue in 2021
3.5 Global Companies Pharmacogenomics (PGx) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pharmacogenomics (PGx) Players in Global Market
3.6.1 List of Global Tier 1 Pharmacogenomics (PGx) Companies
3.6.2 List of Global Tier 2 and Tier 3 Pharmacogenomics (PGx) Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Pharmacogenomics (PGx) Market Size Markets, 2021 & 2028
4.1.2 Polymerase Chain Reaction (PCR)
4.1.3 Microarray
4.1.4 Sequencing
4.1.5 Other
4.2 By Type - Global Pharmacogenomics (PGx) Revenue & Forecasts
4.2.1 By Type - Global Pharmacogenomics (PGx) Revenue, 2017-2022
4.2.2 By Type - Global Pharmacogenomics (PGx) Revenue, 2023-2028
4.2.3 By Type - Global Pharmacogenomics (PGx) Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Pharmacogenomics (PGx) Market Size, 2021 & 2028
5.1.2 Cardiovascular Diseases (CVD)
5.1.3 Central Nervous System (CNS)
5.1.4 Cancer/Oncology
5.1.5 Infectious Diseases
5.1.6 Other
5.2 By Application - Global Pharmacogenomics (PGx) Revenue & Forecasts
5.2.1 By Application - Global Pharmacogenomics (PGx) Revenue, 2017-2022
5.2.2 By Application - Global Pharmacogenomics (PGx) Revenue, 2023-2028
5.2.3 By Application - Global Pharmacogenomics (PGx) Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Pharmacogenomics (PGx) Market Size, 2021 & 2028
6.2 By Region - Global Pharmacogenomics (PGx) Revenue & Forecasts
6.2.1 By Region - Global Pharmacogenomics (PGx) Revenue, 2017-2022
6.2.2 By Region - Global Pharmacogenomics (PGx) Revenue, 2023-2028
6.2.3 By Region - Global Pharmacogenomics (PGx) Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Pharmacogenomics (PGx) Revenue, 2017-2028
6.3.2 US Pharmacogenomics (PGx) Market Size, 2017-2028
6.3.3 Canada Pharmacogenomics (PGx) Market Size, 2017-2028
6.3.4 Mexico Pharmacogenomics (PGx) Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Pharmacogenomics (PGx) Revenue, 2017-2028
6.4.2 Germany Pharmacogenomics (PGx) Market Size, 2017-2028
6.4.3 France Pharmacogenomics (PGx) Market Size, 2017-2028
6.4.4 U.K. Pharmacogenomics (PGx) Market Size, 2017-2028
6.4.5 Italy Pharmacogenomics (PGx) Market Size, 2017-2028
6.4.6 Russia Pharmacogenomics (PGx) Market Size, 2017-2028
6.4.7 Nordic Countries Pharmacogenomics (PGx) Market Size, 2017-2028
6.4.8 Benelux Pharmacogenomics (PGx) Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Pharmacogenomics (PGx) Revenue, 2017-2028
6.5.2 China Pharmacogenomics (PGx) Market Size, 2017-2028
6.5.3 Japan Pharmacogenomics (PGx) Market Size, 2017-2028
6.5.4 South Korea Pharmacogenomics (PGx) Market Size, 2017-2028
6.5.5 Southeast Asia Pharmacogenomics (PGx) Market Size, 2017-2028
6.5.6 India Pharmacogenomics (PGx) Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Pharmacogenomics (PGx) Revenue, 2017-2028
6.6.2 Brazil Pharmacogenomics (PGx) Market Size, 2017-2028
6.6.3 Argentina Pharmacogenomics (PGx) Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pharmacogenomics (PGx) Revenue, 2017-2028
6.7.2 Turkey Pharmacogenomics (PGx) Market Size, 2017-2028
6.7.3 Israel Pharmacogenomics (PGx) Market Size, 2017-2028
6.7.4 Saudi Arabia Pharmacogenomics (PGx) Market Size, 2017-2028
6.7.5 UAE Pharmacogenomics (PGx) Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Corporate Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Pharmacogenomics (PGx) Major Product Offerings
7.1.4 Abbott Laboratories Pharmacogenomics (PGx) Revenue in Global Market (2017-2022)
7.1.5 Abbott Laboratories Key News
7.2 Affymetrix, Inc.
7.2.1 Affymetrix, Inc. Corporate Summary
7.2.2 Affymetrix, Inc. Business Overview
7.2.3 Affymetrix, Inc. Pharmacogenomics (PGx) Major Product Offerings
7.2.4 Affymetrix, Inc. Pharmacogenomics (PGx) Revenue in Global Market (2017-2022)
7.2.5 Affymetrix, Inc. Key News
7.3 Assurex Health, Inc
7.3.1 Assurex Health, Inc Corporate Summary
7.3.2 Assurex Health, Inc Business Overview
7.3.3 Assurex Health, Inc Pharmacogenomics (PGx) Major Product Offerings
7.3.4 Assurex Health, Inc Pharmacogenomics (PGx) Revenue in Global Market (2017-2022)
7.3.5 Assurex Health, Inc Key News
7.4 Astrazeneca
7.4.1 Astrazeneca Corporate Summary
7.4.2 Astrazeneca Business Overview
7.4.3 Astrazeneca Pharmacogenomics (PGx) Major Product Offerings
7.4.4 Astrazeneca Pharmacogenomics (PGx) Revenue in Global Market (2017-2022)
7.4.5 Astrazeneca Key News
7.5 GeneDX
7.5.1 GeneDX Corporate Summary
7.5.2 GeneDX Business Overview
7.5.3 GeneDX Pharmacogenomics (PGx) Major Product Offerings
7.5.4 GeneDX Pharmacogenomics (PGx) Revenue in Global Market (2017-2022)
7.5.5 GeneDX Key News
7.6 Illumina, Inc.
7.6.1 Illumina, Inc. Corporate Summary
7.6.2 Illumina, Inc. Business Overview
7.6.3 Illumina, Inc. Pharmacogenomics (PGx) Major Product Offerings
7.6.4 Illumina, Inc. Pharmacogenomics (PGx) Revenue in Global Market (2017-2022)
7.6.5 Illumina, Inc. Key News
7.7 Laboratory Corporation of America Holdings
7.7.1 Laboratory Corporation of America Holdings Corporate Summary
7.7.2 Laboratory Corporation of America Holdings Business Overview
7.7.3 Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Major Product Offerings
7.7.4 Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Revenue in Global Market (2017-2022)
7.7.5 Laboratory Corporation of America Holdings Key News
7.8 Myriad Genetics, Inc.
7.8.1 Myriad Genetics, Inc. Corporate Summary
7.8.2 Myriad Genetics, Inc. Business Overview
7.8.3 Myriad Genetics, Inc. Pharmacogenomics (PGx) Major Product Offerings
7.8.4 Myriad Genetics, Inc. Pharmacogenomics (PGx) Revenue in Global Market (2017-2022)
7.8.5 Myriad Genetics, Inc. Key News
7.9 Pathway Genomics
7.9.1 Pathway Genomics Corporate Summary
7.9.2 Pathway Genomics Business Overview
7.9.3 Pathway Genomics Pharmacogenomics (PGx) Major Product Offerings
7.9.4 Pathway Genomics Pharmacogenomics (PGx) Revenue in Global Market (2017-2022)
7.9.5 Pathway Genomics Key News
7.10 Pfizer, Inc
7.10.1 Pfizer, Inc Corporate Summary
7.10.2 Pfizer, Inc Business Overview
7.10.3 Pfizer, Inc Pharmacogenomics (PGx) Major Product Offerings
7.10.4 Pfizer, Inc Pharmacogenomics (PGx) Revenue in Global Market (2017-2022)
7.10.5 Pfizer, Inc Key News
7.11 Qiagen, Inc.
7.11.1 Qiagen, Inc. Corporate Summary
7.11.2 Qiagen, Inc. Business Overview
7.11.3 Qiagen, Inc. Pharmacogenomics (PGx) Major Product Offerings
7.11.4 Qiagen, Inc. Pharmacogenomics (PGx) Revenue in Global Market (2017-2022)
7.11.5 Qiagen, Inc. Key News
7.12 Rocheg
7.12.1 Rocheg Corporate Summary
7.12.2 Rocheg Business Overview
7.12.3 Rocheg Pharmacogenomics (PGx) Major Product Offerings
7.12.4 Rocheg Pharmacogenomics (PGx) Revenue in Global Market (2017-2022)
7.12.5 Rocheg Key News
7.13 Teva Pharmaceutical Industries Ltd.
7.13.1 Teva Pharmaceutical Industries Ltd. Corporate Summary
7.13.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.13.3 Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Major Product Offerings
7.13.4 Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Revenue in Global Market (2017-2022)
7.13.5 Teva Pharmaceutical Industries Ltd. Key News
7.14 Thermo Fisher Scientific
7.14.1 Thermo Fisher Scientific Corporate Summary
7.14.2 Thermo Fisher Scientific Business Overview
7.14.3 Thermo Fisher Scientific Pharmacogenomics (PGx) Major Product Offerings
7.14.4 Thermo Fisher Scientific Pharmacogenomics (PGx) Revenue in Global Market (2017-2022)
7.14.5 Thermo Fisher Scientific Key News
7.15 Transgenomic, Inc.
7.15.1 Transgenomic, Inc. Corporate Summary
7.15.2 Transgenomic, Inc. Business Overview
7.15.3 Transgenomic, Inc. Pharmacogenomics (PGx) Major Product Offerings
7.15.4 Transgenomic, Inc. Pharmacogenomics (PGx) Revenue in Global Market (2017-2022)
7.15.5 Transgenomic, Inc. Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. Pharmacogenomics (PGx) Market Opportunities & Trends in Global Market
Table 2. Pharmacogenomics (PGx) Market Drivers in Global Market
Table 3. Pharmacogenomics (PGx) Market Restraints in Global Market
Table 4. Key Players of Pharmacogenomics (PGx) in Global Market
Table 5. Top Pharmacogenomics (PGx) Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Pharmacogenomics (PGx) Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Pharmacogenomics (PGx) Revenue Share by Companies, 2017-2022
Table 8. Global Companies Pharmacogenomics (PGx) Product Type
Table 9. List of Global Tier 1 Pharmacogenomics (PGx) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pharmacogenomics (PGx) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Pharmacogenomics (PGx) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Pharmacogenomics (PGx) Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Pharmacogenomics (PGx) Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Pharmacogenomics (PGx) Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Pharmacogenomics (PGx) Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Pharmacogenomics (PGx) Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Pharmacogenomics (PGx) Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Pharmacogenomics (PGx) Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Pharmacogenomics (PGx) Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Pharmacogenomics (PGx) Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Pharmacogenomics (PGx) Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Pharmacogenomics (PGx) Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Pharmacogenomics (PGx) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Pharmacogenomics (PGx) Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Laboratories Corporate Summary
Table 31. Abbott Laboratories Pharmacogenomics (PGx) Product Offerings
Table 32. Abbott Laboratories Pharmacogenomics (PGx) Revenue (US$, Mn), (2017-2022)
Table 33. Affymetrix, Inc. Corporate Summary
Table 34. Affymetrix, Inc. Pharmacogenomics (PGx) Product Offerings
Table 35. Affymetrix, Inc. Pharmacogenomics (PGx) Revenue (US$, Mn), (2017-2022)
Table 36. Assurex Health, Inc Corporate Summary
Table 37. Assurex Health, Inc Pharmacogenomics (PGx) Product Offerings
Table 38. Assurex Health, Inc Pharmacogenomics (PGx) Revenue (US$, Mn), (2017-2022)
Table 39. Astrazeneca Corporate Summary
Table 40. Astrazeneca Pharmacogenomics (PGx) Product Offerings
Table 41. Astrazeneca Pharmacogenomics (PGx) Revenue (US$, Mn), (2017-2022)
Table 42. GeneDX Corporate Summary
Table 43. GeneDX Pharmacogenomics (PGx) Product Offerings
Table 44. GeneDX Pharmacogenomics (PGx) Revenue (US$, Mn), (2017-2022)
Table 45. Illumina, Inc. Corporate Summary
Table 46. Illumina, Inc. Pharmacogenomics (PGx) Product Offerings
Table 47. Illumina, Inc. Pharmacogenomics (PGx) Revenue (US$, Mn), (2017-2022)
Table 48. Laboratory Corporation of America Holdings Corporate Summary
Table 49. Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Product Offerings
Table 50. Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Revenue (US$, Mn), (2017-2022)
Table 51. Myriad Genetics, Inc. Corporate Summary
Table 52. Myriad Genetics, Inc. Pharmacogenomics (PGx) Product Offerings
Table 53. Myriad Genetics, Inc. Pharmacogenomics (PGx) Revenue (US$, Mn), (2017-2022)
Table 54. Pathway Genomics Corporate Summary
Table 55. Pathway Genomics Pharmacogenomics (PGx) Product Offerings
Table 56. Pathway Genomics Pharmacogenomics (PGx) Revenue (US$, Mn), (2017-2022)
Table 57. Pfizer, Inc Corporate Summary
Table 58. Pfizer, Inc Pharmacogenomics (PGx) Product Offerings
Table 59. Pfizer, Inc Pharmacogenomics (PGx) Revenue (US$, Mn), (2017-2022)
Table 60. Qiagen, Inc. Corporate Summary
Table 61. Qiagen, Inc. Pharmacogenomics (PGx) Product Offerings
Table 62. Qiagen, Inc. Pharmacogenomics (PGx) Revenue (US$, Mn), (2017-2022)
Table 63. Rocheg Corporate Summary
Table 64. Rocheg Pharmacogenomics (PGx) Product Offerings
Table 65. Rocheg Pharmacogenomics (PGx) Revenue (US$, Mn), (2017-2022)
Table 66. Teva Pharmaceutical Industries Ltd. Corporate Summary
Table 67. Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Product Offerings
Table 68. Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Revenue (US$, Mn), (2017-2022)
Table 69. Thermo Fisher Scientific Corporate Summary
Table 70. Thermo Fisher Scientific Pharmacogenomics (PGx) Product Offerings
Table 71. Thermo Fisher Scientific Pharmacogenomics (PGx) Revenue (US$, Mn), (2017-2022)
Table 72. Transgenomic, Inc. Corporate Summary
Table 73. Transgenomic, Inc. Pharmacogenomics (PGx) Product Offerings
Table 74. Transgenomic, Inc. Pharmacogenomics (PGx) Revenue (US$, Mn), (2017-2022)
Table 1. Pharmacogenomics (PGx) Market Opportunities & Trends in Global Market
Table 2. Pharmacogenomics (PGx) Market Drivers in Global Market
Table 3. Pharmacogenomics (PGx) Market Restraints in Global Market
Table 4. Key Players of Pharmacogenomics (PGx) in Global Market
Table 5. Top Pharmacogenomics (PGx) Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Pharmacogenomics (PGx) Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Pharmacogenomics (PGx) Revenue Share by Companies, 2017-2022
Table 8. Global Companies Pharmacogenomics (PGx) Product Type
Table 9. List of Global Tier 1 Pharmacogenomics (PGx) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pharmacogenomics (PGx) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Pharmacogenomics (PGx) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Pharmacogenomics (PGx) Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Pharmacogenomics (PGx) Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Pharmacogenomics (PGx) Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Pharmacogenomics (PGx) Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Pharmacogenomics (PGx) Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Pharmacogenomics (PGx) Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Pharmacogenomics (PGx) Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Pharmacogenomics (PGx) Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Pharmacogenomics (PGx) Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Pharmacogenomics (PGx) Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Pharmacogenomics (PGx) Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Pharmacogenomics (PGx) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Pharmacogenomics (PGx) Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Laboratories Corporate Summary
Table 31. Abbott Laboratories Pharmacogenomics (PGx) Product Offerings
Table 32. Abbott Laboratories Pharmacogenomics (PGx) Revenue (US$, Mn), (2017-2022)
Table 33. Affymetrix, Inc. Corporate Summary
Table 34. Affymetrix, Inc. Pharmacogenomics (PGx) Product Offerings
Table 35. Affymetrix, Inc. Pharmacogenomics (PGx) Revenue (US$, Mn), (2017-2022)
Table 36. Assurex Health, Inc Corporate Summary
Table 37. Assurex Health, Inc Pharmacogenomics (PGx) Product Offerings
Table 38. Assurex Health, Inc Pharmacogenomics (PGx) Revenue (US$, Mn), (2017-2022)
Table 39. Astrazeneca Corporate Summary
Table 40. Astrazeneca Pharmacogenomics (PGx) Product Offerings
Table 41. Astrazeneca Pharmacogenomics (PGx) Revenue (US$, Mn), (2017-2022)
Table 42. GeneDX Corporate Summary
Table 43. GeneDX Pharmacogenomics (PGx) Product Offerings
Table 44. GeneDX Pharmacogenomics (PGx) Revenue (US$, Mn), (2017-2022)
Table 45. Illumina, Inc. Corporate Summary
Table 46. Illumina, Inc. Pharmacogenomics (PGx) Product Offerings
Table 47. Illumina, Inc. Pharmacogenomics (PGx) Revenue (US$, Mn), (2017-2022)
Table 48. Laboratory Corporation of America Holdings Corporate Summary
Table 49. Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Product Offerings
Table 50. Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Revenue (US$, Mn), (2017-2022)
Table 51. Myriad Genetics, Inc. Corporate Summary
Table 52. Myriad Genetics, Inc. Pharmacogenomics (PGx) Product Offerings
Table 53. Myriad Genetics, Inc. Pharmacogenomics (PGx) Revenue (US$, Mn), (2017-2022)
Table 54. Pathway Genomics Corporate Summary
Table 55. Pathway Genomics Pharmacogenomics (PGx) Product Offerings
Table 56. Pathway Genomics Pharmacogenomics (PGx) Revenue (US$, Mn), (2017-2022)
Table 57. Pfizer, Inc Corporate Summary
Table 58. Pfizer, Inc Pharmacogenomics (PGx) Product Offerings
Table 59. Pfizer, Inc Pharmacogenomics (PGx) Revenue (US$, Mn), (2017-2022)
Table 60. Qiagen, Inc. Corporate Summary
Table 61. Qiagen, Inc. Pharmacogenomics (PGx) Product Offerings
Table 62. Qiagen, Inc. Pharmacogenomics (PGx) Revenue (US$, Mn), (2017-2022)
Table 63. Rocheg Corporate Summary
Table 64. Rocheg Pharmacogenomics (PGx) Product Offerings
Table 65. Rocheg Pharmacogenomics (PGx) Revenue (US$, Mn), (2017-2022)
Table 66. Teva Pharmaceutical Industries Ltd. Corporate Summary
Table 67. Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Product Offerings
Table 68. Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Revenue (US$, Mn), (2017-2022)
Table 69. Thermo Fisher Scientific Corporate Summary
Table 70. Thermo Fisher Scientific Pharmacogenomics (PGx) Product Offerings
Table 71. Thermo Fisher Scientific Pharmacogenomics (PGx) Revenue (US$, Mn), (2017-2022)
Table 72. Transgenomic, Inc. Corporate Summary
Table 73. Transgenomic, Inc. Pharmacogenomics (PGx) Product Offerings
Table 74. Transgenomic, Inc. Pharmacogenomics (PGx) Revenue (US$, Mn), (2017-2022)
LIST OF FIGURES
Figure 1. Pharmacogenomics (PGx) Segment by Type in 2021
Figure 2. Pharmacogenomics (PGx) Segment by Application in 2021
Figure 3. Global Pharmacogenomics (PGx) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Pharmacogenomics (PGx) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Pharmacogenomics (PGx) Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pharmacogenomics (PGx) Revenue in 2021
Figure 8. By Type - Global Pharmacogenomics (PGx) Revenue Market Share, 2017-2028
Figure 9. By Application - Global Pharmacogenomics (PGx) Revenue Market Share, 2017-2028
Figure 10. By Region - Global Pharmacogenomics (PGx) Revenue Market Share, 2017-2028
Figure 11. By Country - North America Pharmacogenomics (PGx) Revenue Market Share, 2017-2028
Figure 12. US Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Pharmacogenomics (PGx) Revenue Market Share, 2017-2028
Figure 16. Germany Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2028
Figure 17. France Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Pharmacogenomics (PGx) Revenue Market Share, 2017-2028
Figure 24. China Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2028
Figure 28. India Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Pharmacogenomics (PGx) Revenue Market Share, 2017-2028
Figure 30. Brazil Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Pharmacogenomics (PGx) Revenue Market Share, 2017-2028
Figure 33. Turkey Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Laboratories Pharmacogenomics (PGx) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Affymetrix, Inc. Pharmacogenomics (PGx) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Assurex Health, Inc Pharmacogenomics (PGx) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Astrazeneca Pharmacogenomics (PGx) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. GeneDX Pharmacogenomics (PGx) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Illumina, Inc. Pharmacogenomics (PGx) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Myriad Genetics, Inc. Pharmacogenomics (PGx) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Pathway Genomics Pharmacogenomics (PGx) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Pfizer, Inc Pharmacogenomics (PGx) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Qiagen, Inc. Pharmacogenomics (PGx) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Rocheg Pharmacogenomics (PGx) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Thermo Fisher Scientific Pharmacogenomics (PGx) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Transgenomic, Inc. Pharmacogenomics (PGx) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 1. Pharmacogenomics (PGx) Segment by Type in 2021
Figure 2. Pharmacogenomics (PGx) Segment by Application in 2021
Figure 3. Global Pharmacogenomics (PGx) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Pharmacogenomics (PGx) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Pharmacogenomics (PGx) Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pharmacogenomics (PGx) Revenue in 2021
Figure 8. By Type - Global Pharmacogenomics (PGx) Revenue Market Share, 2017-2028
Figure 9. By Application - Global Pharmacogenomics (PGx) Revenue Market Share, 2017-2028
Figure 10. By Region - Global Pharmacogenomics (PGx) Revenue Market Share, 2017-2028
Figure 11. By Country - North America Pharmacogenomics (PGx) Revenue Market Share, 2017-2028
Figure 12. US Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Pharmacogenomics (PGx) Revenue Market Share, 2017-2028
Figure 16. Germany Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2028
Figure 17. France Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Pharmacogenomics (PGx) Revenue Market Share, 2017-2028
Figure 24. China Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2028
Figure 28. India Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Pharmacogenomics (PGx) Revenue Market Share, 2017-2028
Figure 30. Brazil Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Pharmacogenomics (PGx) Revenue Market Share, 2017-2028
Figure 33. Turkey Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Pharmacogenomics (PGx) Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Laboratories Pharmacogenomics (PGx) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Affymetrix, Inc. Pharmacogenomics (PGx) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Assurex Health, Inc Pharmacogenomics (PGx) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Astrazeneca Pharmacogenomics (PGx) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. GeneDX Pharmacogenomics (PGx) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Illumina, Inc. Pharmacogenomics (PGx) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Myriad Genetics, Inc. Pharmacogenomics (PGx) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Pathway Genomics Pharmacogenomics (PGx) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Pfizer, Inc Pharmacogenomics (PGx) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Qiagen, Inc. Pharmacogenomics (PGx) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Rocheg Pharmacogenomics (PGx) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Thermo Fisher Scientific Pharmacogenomics (PGx) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Transgenomic, Inc. Pharmacogenomics (PGx) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
